Press Release GANYMED ANNOUNCES LICENSE OF WT1 IMMUNOTHERAPY RIGHTS BY CORIXA AND KIRIN Mainz, Germany June 08, 2004 Ganymed Pharmaceuticals AG, Mainz, Germany, announced today that Corixa Corporation (Nasdaq: CRXA), U - WT1 - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-02-04 05:14:56 WT1 Immunology Corixa Cancer vaccine Immunotherapy		Press Release GANYMED ANNOUNCES LICENSE OF WT1 IMMUNOTHERAPY RIGHTS BY CORIXA AND KIRIN Mainz, Germany / June 08, 2004 Ganymed Pharmaceuticals AG, Mainz, Germany, announced today that Corixa Corporation (Nasdaq: CRXA), U Add to Reading List Source URL: www.ganymed-pharmaceuticals.com Download Document from Source Website File Size: 15,20 KB Share Document on Facebook